Matches in Wikidata for { <http://www.wikidata.org/entity/Q37610507> ?p ?o ?g. }
- Q37610507 description "article científic" @default.
- Q37610507 description "article scientifique" @default.
- Q37610507 description "articolo scientifico" @default.
- Q37610507 description "artigo científico" @default.
- Q37610507 description "artículu científicu espublizáu en 2016" @default.
- Q37610507 description "bilimsel makale" @default.
- Q37610507 description "scientific article published on March 2016" @default.
- Q37610507 description "vedecký článok" @default.
- Q37610507 description "vetenskaplig artikel" @default.
- Q37610507 description "videnskabelig artikel" @default.
- Q37610507 description "vědecký článek" @default.
- Q37610507 description "wetenschappelijk artikel" @default.
- Q37610507 description "wissenschaftlicher Artikel" @default.
- Q37610507 description "наукова стаття, опублікована в березні 2016" @default.
- Q37610507 description "научни чланак" @default.
- Q37610507 description "مقالة علمية نشرت في مارس 2016" @default.
- Q37610507 name "Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study" @default.
- Q37610507 name "Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study" @default.
- Q37610507 name "Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study." @default.
- Q37610507 type Item @default.
- Q37610507 label "Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study" @default.
- Q37610507 label "Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study" @default.
- Q37610507 label "Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study." @default.
- Q37610507 prefLabel "Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study" @default.
- Q37610507 prefLabel "Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study" @default.
- Q37610507 prefLabel "Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study." @default.
- Q37610507 P1433 Q37610507-B637F701-B7CC-4355-B867-ADA82808BD80 @default.
- Q37610507 P1476 Q37610507-A8697C8B-1E53-4D38-9C2E-6EB032CD9DE6 @default.
- Q37610507 P2093 Q37610507-269185B4-7BAA-4049-8691-4A8FB8B5ABCA @default.
- Q37610507 P2093 Q37610507-34FD4DF6-4E97-4D75-8F1F-13ACA5AF52AE @default.
- Q37610507 P2093 Q37610507-48879EE4-8551-4FAD-B364-57BEC0539BC1 @default.
- Q37610507 P2093 Q37610507-490312B8-96A6-4746-89EB-112C3051C1E9 @default.
- Q37610507 P2093 Q37610507-6B93E8AB-4EC4-4EBC-AFB0-40337DD5DD84 @default.
- Q37610507 P2093 Q37610507-6FFD2235-5CBD-4900-B4B6-E53C74BDC21B @default.
- Q37610507 P2093 Q37610507-9803BB7A-DA8A-4601-9076-A9BB87F16ACC @default.
- Q37610507 P2093 Q37610507-A4866B55-7315-4583-9526-ECE54CF4F9D1 @default.
- Q37610507 P2093 Q37610507-C6112970-22E1-4CEF-8444-535245B4D987 @default.
- Q37610507 P2093 Q37610507-E16463A9-ED49-445F-840C-01399E852CB6 @default.
- Q37610507 P275 Q37610507-558560c8-0548-4e2f-a300-bfbd4b36c19b @default.
- Q37610507 P2860 Q37610507-0195883E-4E48-4BF2-A5E8-76601DEF3DA7 @default.
- Q37610507 P2860 Q37610507-05337C74-EB85-4ADA-B7A3-143222782B26 @default.
- Q37610507 P2860 Q37610507-1F35109F-9524-4B2C-AC1C-DCAAE4AEE7A4 @default.
- Q37610507 P2860 Q37610507-28459D54-5B48-4D8A-B270-6317F13F5B26 @default.
- Q37610507 P2860 Q37610507-29B543D3-31A1-4244-90E9-F3BE5E67B1F1 @default.
- Q37610507 P2860 Q37610507-35773B15-84FB-4D9B-B105-AAA201376940 @default.
- Q37610507 P2860 Q37610507-48510703-9F99-4A7E-9FD4-06F07B400ABB @default.
- Q37610507 P2860 Q37610507-65502C54-254E-4A37-AD02-55340CBCDF75 @default.
- Q37610507 P2860 Q37610507-7E566E22-C49B-4DE6-ADB1-1D1B5960F1A0 @default.
- Q37610507 P2860 Q37610507-873ADD56-993B-47B9-B885-B3F30B9B4337 @default.
- Q37610507 P2860 Q37610507-9908FA3A-34BC-490F-A644-A6F282B86B2B @default.
- Q37610507 P2860 Q37610507-A5ADC082-C749-439B-958B-E09249DBB172 @default.
- Q37610507 P2860 Q37610507-ADE61B94-DCDB-4B60-AB3F-9E82C6BA6E36 @default.
- Q37610507 P2860 Q37610507-AE53052D-49B9-47A7-B856-3E3706450B09 @default.
- Q37610507 P2860 Q37610507-B7A6ABF0-2299-4ABE-BA0D-529650750A73 @default.
- Q37610507 P2860 Q37610507-C2F6DFD1-7C98-42EE-B0AE-6A5665E44E64 @default.
- Q37610507 P2860 Q37610507-C3EDFF64-9DFE-454D-8556-2B0E3CDF82EB @default.
- Q37610507 P2860 Q37610507-D02F75D5-C4D0-452C-B658-EE11607F4C62 @default.
- Q37610507 P2860 Q37610507-D5DE8B9A-0D9E-4F50-8EA5-3B2AB5D93A33 @default.
- Q37610507 P2860 Q37610507-FF2A28B0-168B-4423-BC57-D547F6E0024C @default.
- Q37610507 P304 Q37610507-84435BEA-9C91-4CBC-A5E9-06DD08B40E31 @default.
- Q37610507 P31 Q37610507-88C853F1-2ED7-4A31-B799-47EB8AEB3B6C @default.
- Q37610507 P356 Q37610507-39B685E0-1EEE-49B1-854A-2F3316059405 @default.
- Q37610507 P433 Q37610507-F16DCC69-1CD0-418E-B2D5-9FE1218EDF82 @default.
- Q37610507 P478 Q37610507-5A40CA35-EC56-48C6-8FFD-85A188454265 @default.
- Q37610507 P577 Q37610507-2BD91CFF-333D-481C-8066-C7D28C97E705 @default.
- Q37610507 P6216 Q37610507-d26a23df-65c5-4b52-bf1d-75118240a18d @default.
- Q37610507 P698 Q37610507-FF58BFD5-C54F-40BB-9E42-156CE34A1258 @default.
- Q37610507 P921 Q37610507-4C71326D-9696-4D63-A18D-27CD7931A043 @default.
- Q37610507 P932 Q37610507-DEB3F5E6-0249-4AF1-9127-802AF46310E6 @default.
- Q37610507 P356 JND-159900 @default.
- Q37610507 P698 27854209 @default.
- Q37610507 P1433 Q27726242 @default.
- Q37610507 P1476 "Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study" @default.
- Q37610507 P2093 "Alan Pestronk" @default.
- Q37610507 P2093 "Alison Skrinar" @default.
- Q37610507 P2093 "Emil Kakkis" @default.
- Q37610507 P2093 "Heather Lau" @default.
- Q37610507 P2093 "Julia Martinisi" @default.
- Q37610507 P2093 "Perry B Shieh" @default.
- Q37610507 P2093 "Ruhi Ahmed" @default.
- Q37610507 P2093 "Tony Koutsoukos" @default.
- Q37610507 P2093 "Yoseph Caraco" @default.
- Q37610507 P2093 "Zohar Argov" @default.
- Q37610507 P275 Q34179348 @default.
- Q37610507 P2860 Q28214777 @default.
- Q37610507 P2860 Q28251720 @default.
- Q37610507 P2860 Q28305085 @default.
- Q37610507 P2860 Q33557902 @default.
- Q37610507 P2860 Q33666081 @default.
- Q37610507 P2860 Q33790241 @default.
- Q37610507 P2860 Q34229722 @default.
- Q37610507 P2860 Q35383020 @default.
- Q37610507 P2860 Q36022226 @default.
- Q37610507 P2860 Q36417270 @default.
- Q37610507 P2860 Q36772150 @default.
- Q37610507 P2860 Q37556267 @default.
- Q37610507 P2860 Q38602759 @default.
- Q37610507 P2860 Q39979003 @default.
- Q37610507 P2860 Q43430455 @default.
- Q37610507 P2860 Q45345412 @default.